Defining PQAs linked to color change in biotherapeutics during process development
min
Achieve new heights in PTM analysis with confidence and speed. Define critical quality attributes (CQAs) and streamline processes from early to late-stage development with in-depth peptide mapping solutions for next-generation protein therapeutics and standard monoclonal antibodies (mAbs).
A high-resolution mass spectrometry solution that combines powerful MS/MS sensitivity, fragmentation technology and a step-change in data independent acquisition.
EAD is a new paradigm for mass spectrometry. Learn how EAD provides more informed decision-making, accelerates research and development and improves productivity for routine analytical applications.